![CM-Patient-landing-page-image CM-Patient-landing-page-image](https://info.castlebiosciences.com/hs-fs/hubfs/CM-Patient-landing-page-image.png?width=1600&height=500&name=CM-Patient-landing-page-image.png)
DecisionDx-Melanoma is a prognostic test for patients diagnosed with Stage I – III cutaneous melanoma. Our test looks at your tumor biology to predict the risk of your melanoma spreading or coming back.
Download the patient discussion guide to facilitate a conversation with your healthcare to determine if DecisionDx-Melanoma is right for you.
Be your own advocate: Morgan England, stage III melanoma survivor, shares her story
With DecisionDx-Melanoma, you and your doctor can make informed decisions about:
![Artboard 121@4x Artboard 121@4x](https://info.castlebiosciences.com/hs-fs/hubfs/Artboard%20121@4x.png?width=75&height=75&name=Artboard%20121@4x.png)
Treatment
![Artboard 140@4x Artboard 140@4x](https://info.castlebiosciences.com/hs-fs/hubfs/Artboard%20140@4x.png?width=75&height=75&name=Artboard%20140@4x.png)
Follow-up appointments with your dermatologist
![Artboard 124@4x Artboard 124@4x](https://info.castlebiosciences.com/hs-fs/hubfs/Artboard%20124@4x.png?width=75&height=75&name=Artboard%20124@4x.png)
Additional visits with other specialties (referrals)
![Artboard 126@4x Artboard 126@4x](https://info.castlebiosciences.com/hs-fs/hubfs/Artboard%20126@4x.png?width=75&height=75&name=Artboard%20126@4x.png)
Surgical procedures such as a sentinel lymph node biopsy
Hear how physicians use DecisionDx-Melanoma
Why DecisionDx-Melanoma?
![CM Patient Web Graphic-v7 CM Patient Web Graphic-v7](https://info.castlebiosciences.com/hs-fs/hubfs/CM%20Patient%20Web%20Graphic-v7.png?width=2000&height=697&name=CM%20Patient%20Web%20Graphic-v7.png)
Talk to your doctor to determine if the DecisionDx-Melanoma test is right for you.
References
- Berger et al. CMRO. 2016.
- Farberg et al. J Drugs Derm. 2017.
- Dillon et al. CMRO. 2022.
- Bailey et al. JCO PO. 2023.
- Dhillon et al. Arch Dermatol Res. 2023.